跳至主要内容
临床试验/NCT01125059
NCT01125059撤回不适用

The Effect of Methadone on Perioperative Analgesia After Posterior Lumbar Fusion - A Randomized, Placebo-controlled, Double-blinded Study

Northwestern University1 个研究点 分布在 1 个国家开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Hydromorphone postoperative opioid consumption (POC) at 48 hours

研究概览

简要总结

What is the influence of methadone on postoperative analgesia after lumbar interbody fusion in opioid naïve patients or patients who are taking less than equivalent of 15 mg IV morphine each day? What is the incidence of opioid related postoperative side effects after the administration of methadone in the operating room?

详细描述

Hypothesis

  1. We hypothesize that 0.2 mg/kg of methadone will result in decreased postoperative hydromorphone consumption compared to hydromorphone alone in opioid naïve patients or patients who are taking less than the equivalent of 15 mg IV morphine a day undergoing lumbar interbody fusion.
  2. We hypothesize that the incidence of opioid related postoperative side effects will not be increased by the administration of methadone in the operating room.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status I, II, and III, male and non-pregnant female
  • English-speaking patients
  • Ages 18-75 years
  • Undergoing elective one or two level posterior lumbar interbody fusion

排除标准

  • Use of more than the equivalent of 15 mg of IV morphine/24 hr in the past 2 weeks.
  • Use of drugs within the past 6 months that effect the pharmacokinetics or pharmacodynamics of opioids (i.e., benzodiazepines, anti-retroviral agents, rifampin, ketoconazole, erythromycin, or phenytoin).
  • history of substance abuse at any time in the past
  • known QT prolongation
  • Non-elective operations (i.e., cancer or trauma)
  • severe hepatic impairment (serum albumin < 3.0 g/dL in the presence of a history of liver disease)
  • pregnancy
  • inability to operate a patient-controlled analgesia device

研究组 & 干预措施

Methadone Group

Active Comparator

0.2 mg/kg IV methadone

干预措施: Methadone (Drug)

Placebo Group

Placebo Comparator

5 mL saline bolus

干预措施: Saline (Drug)

结局指标

主要结局

Hydromorphone postoperative opioid consumption (POC) at 48 hours

时间窗: 48 hrs

PCA opioid consumption during the initial postoperative 48 hours after arriving in the PACU

次要结局

  • pain at rest and with movement (numerical Rating Scale, NRS)(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs, 48 hrs)
  • number of occurrences of nausea (resulting in treatment)(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs, 48 hrs)
  • recorded emesis(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs, 48 hrs)
  • occurrence of pruritus(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs, 48 hrs)
  • the level of sedation (modified Observer's Assessment of Alertness and Sedation Scale, modified OAA/S scale)(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs, 48 hrs)
  • Hydromorphone postoperative opioid consumption (POC)(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs)
  • Intraoperative remifentanil consumption(the 8 hours prior to arrival in the recovery room)
  • the number of occurrences of ventilatory depression during each evaluation interval(1 hr, 6 hrs, 12 hrs, 24 hrs, 36 hrs, 48 hrs)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dhanesh Gupta

Associate Professor of Anesthesiology & Neurological Surgery

Northwestern University

研究点 (1)

Loading locations...

相似试验